Protein binding chiral discrimination of HPLC stationary phases made with whole, fragmented, and third domain turkey ovomucoid.
Protein binding chiral discrimination of HPLC stationary phases made with whole, fragmented, and third domain turkey ovomucoid.
复制标题
用完整、片段和第三域火鸡卵类粘蛋白制成的 HPLC 固定相的蛋白质结合手性辨别。
DOI:
10.1021/ac00110a006
复制
发表时间:
1995
影响因子:
7.4
通讯作者:
Markley,JL
中科院分区:
文献类型:
--
作者:
Pinkerton,TC;Howe,WJ;Ulrich,EL;Comiskey,JP;Haginaka,J;Murashima,T;Walkenhorst,WF;Westler,WM;Markley,JL
Individual protein domainsand two domains in combina-tion were prepared by enzymatic and chemical cleavage of turkey ovomucoid followed by isolation and purification by size-exclusion and ion-exchange chromatography. Silica bonded-phase HPLC columns were made from either whole or isolated domains of turkey ovomucoid. The protein columns were tested for chiral recognition by their abilities to resolve enantiomers among a wide range of racemates. The columns made from whole turkey ovo-mucoid displayed chiral activity toward many racemates, where as a combination of the first and second domain resolved only a selected number of aromatic weak bases. The first and second domains independently gave no appreciable chiral activity. The turkey ovomucoid third domain exhibited enantioselective protein binding for fused-ring aromatic weak acids. Gtycosylation of the third domain did not affect chiral recognition. Titration of the third domain with model compounds in conjunction with NMR measurements enabled the identification of the amino acids responsible for binding. Molecular modeling of the ligand-protein complexation provided insights into the ability of a protein surfaceto discriminate enantiomers on the basis of multiple intermolecular interactions.Over the past decade, many HPLC chiral stationary phases have been developed to separate enantiomers with each phase employing its own unique separation strategy. 12 Since chiral recognition properties are highly specific, a large number of enantioselective phases have been designed to separate an extensive array of chiral compounds. These phases generate chiral resolution by ligand-exchange complexation,. T-donor/